Our Firm is currently evaluating potential testosterone treatment lawsuits on behalf of men who allegedly experienced life-threatening cardiovascular problems due to this class of medications.
New York, New York (PRWEB) October 30, 2014
Hundreds of testosterone lawsuits (http://www.testosteronelawsuithub.com/) filed against the manufacturers of medications like AndroGel, AndroDerm and Testim continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, Bernstein Liebhard LLP reports. According to a Case Management Order dated October 24th, the Court will now allow direct filing of testosterone treatment lawsuits in the proceeding. This directive is intended to eliminate potential delays associated with transferring cases from other federal courts. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
“Our Firm is currently evaluating potential testosterone treatment lawsuits on behalf of men who allegedly experienced life-threatening cardiovascular problems due to this class of medications. We are pleased to see that the federal litigation is progressing in such an efficient manner,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free legal evaluations to men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism and other life-threatening heart problems due to their use of prescription testosterone medications.
Court documents indicate that more than 220 testosterone treatment lawsuits are now pending in the federal multidistrict litigation underway in the Northern District of Illinois. The litigation has been growing since January, when the U.S. Food & Drug Administration (FDA) announced that it was investigating the cardiovascular risks associated with low testosterone therapy. The agency acted after two studies indicated the drugs could increase the risk of heart attacks, strokes and sudden death in older men, as well as those with pre-existing heart disease.
Just last month, a panel of FDA advisors recommended that the labels for prescription testosterone medications be revised to make clear they have not been shown to lessen symptoms related to age-related reductions in testosterone levels. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*
Victims of heart attacks, strokes, blood clots and other cardiovascular events allegedly related to the use of low testosterone therapy may be entitled to compensation for any injury-related damages they incurred. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 18, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com